To identify prognostic factors affecting thrombosis-free survival (TFS) and overall survival (OS), we report the experience of a Regional cooperative group in a real-life cohort of 1,144 patients with essential thrombocythemia (ET) diagnosed from January 1979 to December 2010. There were 107 thrombotic events (9.4%) during follow-up [60 (5.3%) arterial and 47 (4.1%) venous thromboses]. At univariate analysis, risk factors for a shorter TFS were: age >60 years (P 60 years (P 15 × 10(9) /l (P = 0.0370) were independent risk factors. Previous thrombotic events in ET patients are crucial for TFS but their importance seems related not to the occurrence per se but mainly to the interval between the event and the diagnosi
ObjectiveTo further understand the factors that promote thrombosis in essential thrombocythemia (ET)...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...
Accurate prediction of thrombosis in essential thrombocythemia (ET) provides the platform for prospe...
ObjectivesStandard risk stratification for overall survival (OS) in patients with essential thromboc...
In an international collaborative study, a central histologic review identified 891 patients with es...
none6Established risk factors for thrombosis in essential thrombocythemia (ET) include age (≥ 60 yea...
The conventional thrombotic risk stratification in essential thrombocythemia (ET) distinguishes pati...
Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients with this d...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...
In an international collaborative study, a central histologic review identified 891 pa-tients with e...
The major causes of morbidity and mortality in essential thrombocythemia (ET) are bleeding and throm...
ObjectiveTo further understand the factors that promote thrombosis in essential thrombocythemia (ET)...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...
Accurate prediction of thrombosis in essential thrombocythemia (ET) provides the platform for prospe...
ObjectivesStandard risk stratification for overall survival (OS) in patients with essential thromboc...
In an international collaborative study, a central histologic review identified 891 patients with es...
none6Established risk factors for thrombosis in essential thrombocythemia (ET) include age (≥ 60 yea...
The conventional thrombotic risk stratification in essential thrombocythemia (ET) distinguishes pati...
Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients with this d...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...
In an international collaborative study, a central histologic review identified 891 pa-tients with e...
The major causes of morbidity and mortality in essential thrombocythemia (ET) are bleeding and throm...
ObjectiveTo further understand the factors that promote thrombosis in essential thrombocythemia (ET)...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...
Accurate prediction of thrombosis in essential thrombocythemia (ET) provides the platform for prospe...